SREBF1 and metabolic dysfunction-associated steatotic liver disease: Under NAFLD conditions, the enhanced expression of proteins associated with lipogenesis-related genes, including ACC, SREBP-1, and FAS, in hepatocytes leads to increased insulin resistance (Hsu et al., 2016).